カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のファブラザイム（アガルシダーゼベータ）市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Fabrazyme (agalsidase beta) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19311）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19311
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：72
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のファブラザイム（アガルシダーゼベータ）市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ファブラザイム（アガルシダーゼベータ）市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のファブラザイム（アガルシダーゼベータ）の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ファブラザイム（アガルシダーゼベータ）市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・5mg/バイアル、35mg/バイアル

用途別セグメントは次のように区分されます。
・病院、ドラッグストア

世界のファブラザイム（アガルシダーゼベータ）市場の主要な市場プレーヤーは以下のとおりです。
・Genzyme Corporation

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ファブラザイム（アガルシダーゼベータ）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なファブラザイム（アガルシダーゼベータ）メーカーの企業概要、2019年～2022年までのファブラザイム（アガルシダーゼベータ）の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なファブラザイム（アガルシダーゼベータ）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ファブラザイム（アガルシダーゼベータ）の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのファブラザイム（アガルシダーゼベータ）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのファブラザイム（アガルシダーゼベータ）市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびファブラザイム（アガルシダーゼベータ）の産業チェーンを掲載しています。
・第13、14、15章では、ファブラザイム（アガルシダーゼベータ）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ファブラザイム（アガルシダーゼベータ）の概要
- 種類別分析（2017年vs2021年vs2028年）：5mg/バイアル、35mg/バイアル
- 用途別分析（2017年vs2021年vs2028年）：病院、ドラッグストア
- 世界のファブラザイム（アガルシダーゼベータ）市場規模・予測
- 世界のファブラザイム（アガルシダーゼベータ）生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Genzyme Corporation
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：5mg/バイアル、35mg/バイアル
・用途別分析2017年-2028年：病院、ドラッグストア
・ファブラザイム（アガルシダーゼベータ）の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ファブラザイム（アガルシダーゼベータ）のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ファブラザイム（アガルシダーゼベータ）のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ファブラザイム（アガルシダーゼベータ）の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ファブラザイム（アガルシダーゼベータ）の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Fabrazyme (agalsidase beta) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Fabrazyme (agalsidase beta) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Fabrazyme (agalsidase beta) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 5mg/vial segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Fabrazyme (agalsidase beta) include Genzyme Corporation, , , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Fabrazyme (agalsidase beta) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
5mg/vial
35mg/vial
Market segment by Application can be divided into
Hospital
Drug store
The key market players for global Fabrazyme (agalsidase beta) market are listed below:
Genzyme Corporation
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Fabrazyme (agalsidase beta) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Fabrazyme (agalsidase beta), with price, sales, revenue and global market share of Fabrazyme (agalsidase beta) from 2019 to 2022.
Chapter 3, the Fabrazyme (agalsidase beta) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Fabrazyme (agalsidase beta) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Fabrazyme (agalsidase beta) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Fabrazyme (agalsidase beta).
Chapter 13, 14, and 15, to describe Fabrazyme (agalsidase beta) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Fabrazyme (agalsidase beta) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Fabrazyme (agalsidase beta) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 5mg/vial
1.2.3 35mg/vial
1.3 Market Analysis by Application
1.3.1 Overview: Global Fabrazyme (agalsidase beta) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Fabrazyme (agalsidase beta) Market Size & Forecast
1.4.1 Global Fabrazyme (agalsidase beta) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Fabrazyme (agalsidase beta) Sales in Volume (2017-2028)
1.4.3 Global Fabrazyme (agalsidase beta) Price (2017-2028)
1.5 Global Fabrazyme (agalsidase beta) Production Capacity Analysis
1.5.1 Global Fabrazyme (agalsidase beta) Total Production Capacity (2017-2028)
1.5.2 Global Fabrazyme (agalsidase beta) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Fabrazyme (agalsidase beta) Market Drivers
1.6.2 Fabrazyme (agalsidase beta) Market Restraints
1.6.3 Fabrazyme (agalsidase beta) Trends Analysis
2 Manufacturers Profiles
2.1 Genzyme Corporation
2.1.1 Genzyme Corporation Details
2.1.2 Genzyme Corporation Major Business
2.1.3 Genzyme Corporation Fabrazyme (agalsidase beta) Product and Services
2.1.4 Genzyme Corporation Fabrazyme (agalsidase beta) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Fabrazyme (agalsidase beta) Breakdown Data by Manufacturer
3.1 Global Fabrazyme (agalsidase beta) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Fabrazyme (agalsidase beta) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Fabrazyme (agalsidase beta)
3.4 Market Concentration Rate
3.4.1 Top 3 Fabrazyme (agalsidase beta) Manufacturer Market Share in 2021
3.4.2 Top 6 Fabrazyme (agalsidase beta) Manufacturer Market Share in 2021
3.5 Global Fabrazyme (agalsidase beta) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Fabrazyme (agalsidase beta) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Fabrazyme (agalsidase beta) Market Size by Region
4.1.1 Global Fabrazyme (agalsidase beta) Sales in Volume by Region (2017-2028)
4.1.2 Global Fabrazyme (agalsidase beta) Revenue by Region (2017-2028)
4.2 North America Fabrazyme (agalsidase beta) Revenue (2017-2028)
4.3 Europe Fabrazyme (agalsidase beta) Revenue (2017-2028)
4.4 Asia-Pacific Fabrazyme (agalsidase beta) Revenue (2017-2028)
4.5 South America Fabrazyme (agalsidase beta) Revenue (2017-2028)
4.6 Middle East and Africa Fabrazyme (agalsidase beta) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Fabrazyme (agalsidase beta) Sales in Volume by Type (2017-2028)
5.2 Global Fabrazyme (agalsidase beta) Revenue by Type (2017-2028)
5.3 Global Fabrazyme (agalsidase beta) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Fabrazyme (agalsidase beta) Sales in Volume by Application (2017-2028)
6.2 Global Fabrazyme (agalsidase beta) Revenue by Application (2017-2028)
6.3 Global Fabrazyme (agalsidase beta) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Fabrazyme (agalsidase beta) Sales by Type (2017-2028)
7.2 North America Fabrazyme (agalsidase beta) Sales by Application (2017-2028)
7.3 North America Fabrazyme (agalsidase beta) Market Size by Country
7.3.1 North America Fabrazyme (agalsidase beta) Sales in Volume by Country (2017-2028)
7.3.2 North America Fabrazyme (agalsidase beta) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Fabrazyme (agalsidase beta) Sales by Type (2017-2028)
8.2 Europe Fabrazyme (agalsidase beta) Sales by Application (2017-2028)
8.3 Europe Fabrazyme (agalsidase beta) Market Size by Country
8.3.1 Europe Fabrazyme (agalsidase beta) Sales in Volume by Country (2017-2028)
8.3.2 Europe Fabrazyme (agalsidase beta) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Fabrazyme (agalsidase beta) Sales by Type (2017-2028)
9.2 Asia-Pacific Fabrazyme (agalsidase beta) Sales by Application (2017-2028)
9.3 Asia-Pacific Fabrazyme (agalsidase beta) Market Size by Region
9.3.1 Asia-Pacific Fabrazyme (agalsidase beta) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Fabrazyme (agalsidase beta) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Fabrazyme (agalsidase beta) Sales by Type (2017-2028)
10.2 South America Fabrazyme (agalsidase beta) Sales by Application (2017-2028)
10.3 South America Fabrazyme (agalsidase beta) Market Size by Country
10.3.1 South America Fabrazyme (agalsidase beta) Sales in Volume by Country (2017-2028)
10.3.2 South America Fabrazyme (agalsidase beta) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Fabrazyme (agalsidase beta) Sales by Type (2017-2028)
11.2 Middle East & Africa Fabrazyme (agalsidase beta) Sales by Application (2017-2028)
11.3 Middle East & Africa Fabrazyme (agalsidase beta) Market Size by Country
11.3.1 Middle East & Africa Fabrazyme (agalsidase beta) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Fabrazyme (agalsidase beta) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Fabrazyme (agalsidase beta) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Fabrazyme (agalsidase beta)
12.3 Fabrazyme (agalsidase beta) Production Process
12.4 Fabrazyme (agalsidase beta) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Fabrazyme (agalsidase beta) Typical Distributors
13.3 Fabrazyme (agalsidase beta) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Fabrazyme (agalsidase beta) Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Fabrazyme (agalsidase beta) Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Genzyme Corporation Basic Information, Manufacturing Base and Competitors
Table 4. Genzyme Corporation Major Business
Table 5. Genzyme Corporation Fabrazyme (agalsidase beta) Product and Services
Table 6. Genzyme Corporation Fabrazyme (agalsidase beta) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Global Fabrazyme (agalsidase beta) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 8. Global Fabrazyme (agalsidase beta) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 9. Market Position of Manufacturers in Fabrazyme (agalsidase beta), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 10. Global Fabrazyme (agalsidase beta) Production Capacity by Company, (K Units): 2020 VS 2021
Table 11. Head Office and Fabrazyme (agalsidase beta) Production Site of Key Manufacturer
Table 12. Fabrazyme (agalsidase beta) New Entrant and Capacity Expansion Plans
Table 13. Fabrazyme (agalsidase beta) Mergers & Acquisitions in the Past Five Years
Table 14. Global Fabrazyme (agalsidase beta) Sales by Region (2017-2022) & (K Units)
Table 15. Global Fabrazyme (agalsidase beta) Sales by Region (2023-2028) & (K Units)
Table 16. Global Fabrazyme (agalsidase beta) Revenue by Region (2017-2022) & (USD Million)
Table 17. Global Fabrazyme (agalsidase beta) Revenue by Region (2023-2028) & (USD Million)
Table 18. Global Fabrazyme (agalsidase beta) Sales by Type (2017-2022) & (K Units)
Table 19. Global Fabrazyme (agalsidase beta) Sales by Type (2023-2028) & (K Units)
Table 20. Global Fabrazyme (agalsidase beta) Revenue by Type (2017-2022) & (USD Million)
Table 21. Global Fabrazyme (agalsidase beta) Revenue by Type (2023-2028) & (USD Million)
Table 22. Global Fabrazyme (agalsidase beta) Price by Type (2017-2022) & (USD/Unit)
Table 23. Global Fabrazyme (agalsidase beta) Price by Type (2023-2028) & (USD/Unit)
Table 24. Global Fabrazyme (agalsidase beta) Sales by Application (2017-2022) & (K Units)
Table 25. Global Fabrazyme (agalsidase beta) Sales by Application (2023-2028) & (K Units)
Table 26. Global Fabrazyme (agalsidase beta) Revenue by Application (2017-2022) & (USD Million)
Table 27. Global Fabrazyme (agalsidase beta) Revenue by Application (2023-2028) & (USD Million)
Table 28. Global Fabrazyme (agalsidase beta) Price by Application (2017-2022) & (USD/Unit)
Table 29. Global Fabrazyme (agalsidase beta) Price by Application (2023-2028) & (USD/Unit)
Table 30. North America Fabrazyme (agalsidase beta) Sales by Country (2017-2022) & (K Units)
Table 31. North America Fabrazyme (agalsidase beta) Sales by Country (2023-2028) & (K Units)
Table 32. North America Fabrazyme (agalsidase beta) Revenue by Country (2017-2022) & (USD Million)
Table 33. North America Fabrazyme (agalsidase beta) Revenue by Country (2023-2028) & (USD Million)
Table 34. North America Fabrazyme (agalsidase beta) Sales by Type (2017-2022) & (K Units)
Table 35. North America Fabrazyme (agalsidase beta) Sales by Type (2023-2028) & (K Units)
Table 36. North America Fabrazyme (agalsidase beta) Sales by Application (2017-2022) & (K Units)
Table 37. North America Fabrazyme (agalsidase beta) Sales by Application (2023-2028) & (K Units)
Table 38. Europe Fabrazyme (agalsidase beta) Sales by Country (2017-2022) & (K Units)
Table 39. Europe Fabrazyme (agalsidase beta) Sales by Country (2023-2028) & (K Units)
Table 40. Europe Fabrazyme (agalsidase beta) Revenue by Country (2017-2022) & (USD Million)
Table 41. Europe Fabrazyme (agalsidase beta) Revenue by Country (2023-2028) & (USD Million)
Table 42. Europe Fabrazyme (agalsidase beta) Sales by Type (2017-2022) & (K Units)
Table 43. Europe Fabrazyme (agalsidase beta) Sales by Type (2023-2028) & (K Units)
Table 44. Europe Fabrazyme (agalsidase beta) Sales by Application (2017-2022) & (K Units)
Table 45. Europe Fabrazyme (agalsidase beta) Sales by Application (2023-2028) & (K Units)
Table 46. Asia-Pacific Fabrazyme (agalsidase beta) Sales by Region (2017-2022) & (K Units)
Table 47. Asia-Pacific Fabrazyme (agalsidase beta) Sales by Region (2023-2028) & (K Units)
Table 48. Asia-Pacific Fabrazyme (agalsidase beta) Revenue by Region (2017-2022) & (USD Million)
Table 49. Asia-Pacific Fabrazyme (agalsidase beta) Revenue by Region (2023-2028) & (USD Million)
Table 50. Asia-Pacific Fabrazyme (agalsidase beta) Sales by Type (2017-2022) & (K Units)
Table 51. Asia-Pacific Fabrazyme (agalsidase beta) Sales by Type (2023-2028) & (K Units)
Table 52. Asia-Pacific Fabrazyme (agalsidase beta) Sales by Application (2017-2022) & (K Units)
Table 53. Asia-Pacific Fabrazyme (agalsidase beta) Sales by Application (2023-2028) & (K Units)
Table 54. South America Fabrazyme (agalsidase beta) Sales by Country (2017-2022) & (K Units)
Table 55. South America Fabrazyme (agalsidase beta) Sales by Country (2023-2028) & (K Units)
Table 56. South America Fabrazyme (agalsidase beta) Revenue by Country (2017-2022) & (USD Million)
Table 57. South America Fabrazyme (agalsidase beta) Revenue by Country (2023-2028) & (USD Million)
Table 58. South America Fabrazyme (agalsidase beta) Sales by Type (2017-2022) & (K Units)
Table 59. South America Fabrazyme (agalsidase beta) Sales by Type (2023-2028) & (K Units)
Table 60. South America Fabrazyme (agalsidase beta) Sales by Application (2017-2022) & (K Units)
Table 61. South America Fabrazyme (agalsidase beta) Sales by Application (2023-2028) & (K Units)
Table 62. Middle East & Africa Fabrazyme (agalsidase beta) Sales by Region (2017-2022) & (K Units)
Table 63. Middle East & Africa Fabrazyme (agalsidase beta) Sales by Region (2023-2028) & (K Units)
Table 64. Middle East & Africa Fabrazyme (agalsidase beta) Revenue by Region (2017-2022) & (USD Million)
Table 65. Middle East & Africa Fabrazyme (agalsidase beta) Revenue by Region (2023-2028) & (USD Million)
Table 66. Middle East & Africa Fabrazyme (agalsidase beta) Sales by Type (2017-2022) & (K Units)
Table 67. Middle East & Africa Fabrazyme (agalsidase beta) Sales by Type (2023-2028) & (K Units)
Table 68. Middle East & Africa Fabrazyme (agalsidase beta) Sales by Application (2017-2022) & (K Units)
Table 69. Middle East & Africa Fabrazyme (agalsidase beta) Sales by Application (2023-2028) & (K Units)
Table 70. Fabrazyme (agalsidase beta) Raw Material
Table 71. Key Manufacturers of Fabrazyme (agalsidase beta) Raw Materials
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Fabrazyme (agalsidase beta) Typical Distributors
Table 75. Fabrazyme (agalsidase beta) Typical Customers
List of Figures
Figure 1. Fabrazyme (agalsidase beta) Picture
Figure 2. Global Fabrazyme (agalsidase beta) Revenue Market Share by Type in 2021
Figure 3. 5mg/vial
Figure 4. 35mg/vial
Figure 5. Global Fabrazyme (agalsidase beta) Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Drug store
Figure 8. Global Fabrazyme (agalsidase beta) Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Fabrazyme (agalsidase beta) Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Fabrazyme (agalsidase beta) Sales (2017-2028) & (K Units)
Figure 11. Global Fabrazyme (agalsidase beta) Price (2017-2028) & (USD/Unit)
Figure 12. Global Fabrazyme (agalsidase beta) Production Capacity (2017-2028) & (K Units)
Figure 13. Global Fabrazyme (agalsidase beta) Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Fabrazyme (agalsidase beta) Market Drivers
Figure 15. Fabrazyme (agalsidase beta) Market Restraints
Figure 16. Fabrazyme (agalsidase beta) Market Trends
Figure 17. Global Fabrazyme (agalsidase beta) Sales Market Share by Manufacturer in 2021
Figure 18. Global Fabrazyme (agalsidase beta) Revenue Market Share by Manufacturer in 2021
Figure 19. Fabrazyme (agalsidase beta) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Fabrazyme (agalsidase beta) Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Fabrazyme (agalsidase beta) Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Fabrazyme (agalsidase beta) Sales Market Share by Region (2017-2028)
Figure 23. Global Fabrazyme (agalsidase beta) Revenue Market Share by Region (2017-2028)
Figure 24. North America Fabrazyme (agalsidase beta) Revenue (2017-2028) & (USD Million)
Figure 25. Europe Fabrazyme (agalsidase beta) Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Fabrazyme (agalsidase beta) Revenue (2017-2028) & (USD Million)
Figure 27. South America Fabrazyme (agalsidase beta) Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Fabrazyme (agalsidase beta) Revenue (2017-2028) & (USD Million)
Figure 29. Global Fabrazyme (agalsidase beta) Sales Market Share by Type (2017-2028)
Figure 30. Global Fabrazyme (agalsidase beta) Revenue Market Share by Type (2017-2028)
Figure 31. Global Fabrazyme (agalsidase beta) Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Fabrazyme (agalsidase beta) Sales Market Share by Application (2017-2028)
Figure 33. Global Fabrazyme (agalsidase beta) Revenue Market Share by Application (2017-2028)
Figure 34. Global Fabrazyme (agalsidase beta) Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Fabrazyme (agalsidase beta) Sales Market Share by Type (2017-2028)
Figure 36. North America Fabrazyme (agalsidase beta) Sales Market Share by Application (2017-2028)
Figure 37. North America Fabrazyme (agalsidase beta) Sales Market Share by Country (2017-2028)
Figure 38. North America Fabrazyme (agalsidase beta) Revenue Market Share by Country (2017-2028)
Figure 39. United States Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Fabrazyme (agalsidase beta) Sales Market Share by Type (2017-2028)
Figure 43. Europe Fabrazyme (agalsidase beta) Sales Market Share by Application (2017-2028)
Figure 44. Europe Fabrazyme (agalsidase beta) Sales Market Share by Country (2017-2028)
Figure 45. Europe Fabrazyme (agalsidase beta) Revenue Market Share by Country (2017-2028)
Figure 46. Germany Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Fabrazyme (agalsidase beta) Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Fabrazyme (agalsidase beta) Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Fabrazyme (agalsidase beta) Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Fabrazyme (agalsidase beta) Revenue Market Share by Region (2017-2028)
Figure 55. China Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Fabrazyme (agalsidase beta) Sales Market Share by Type (2017-2028)
Figure 62. South America Fabrazyme (agalsidase beta) Sales Market Share by Application (2017-2028)
Figure 63. South America Fabrazyme (agalsidase beta) Sales Market Share by Country (2017-2028)
Figure 64. South America Fabrazyme (agalsidase beta) Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Fabrazyme (agalsidase beta) Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Fabrazyme (agalsidase beta) Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Fabrazyme (agalsidase beta) Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Fabrazyme (agalsidase beta) Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Fabrazyme (agalsidase beta) Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Fabrazyme (agalsidase beta) in 2021
Figure 76. Manufacturing Process Analysis of Fabrazyme (agalsidase beta)
Figure 77. Fabrazyme (agalsidase beta) Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のベータ-2 ミクログロブリン (B2M)市場2022年：市場規模予測（～2028年）
  • 世界のベータヒドロキシブチレート塩 (BHB)市場2022年：市場規模予測（～2028年）
  • 世界のβ-メチルビニルホスフェート (MAP)市場2022年：市場規模予測（～2028年）
  • 世界の筋強直性ジストロフィー1型（DM1）市場2022年：市場規模予測（～2028年）
  • 世界の血栓活性剤（BCA）市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19311 )"世界のファブラザイム（アガルシダーゼベータ）市場2022年：市場規模予測（～2028年）" (英文：Global Fabrazyme (agalsidase beta) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。